{"date":"2026-06-18","count":32,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7827-2026-06-18-2050-3sk96k","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"20:50:12","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-06-18 20:50，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-06-18-2038-wew0ye","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"20:38:43","subject":"公告本公司董事會決議發行低於市價之員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-06-18 20:38，「公告本公司董事會決議發行低於市價之員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-06-18-2017-1jixu6b","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"20:17:02","subject":"公告本公司董事會決議召開115年第一次股東臨時會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-06-18 20:17，「公告本公司董事會決議召開115年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-06-18-1916-1a2hry0","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"19:16:31","subject":"公告本公司獲代理商通知 -本公司新藥產品Stemchymal已向日本主管機關提出「製造販賣業許可 (MAH)」審查申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-06-18 19:16，「公告本公司獲代理商通知 -本公司新藥產品Stemchymal已向日本主管機關提出「製造販賣業許可 (MAH)」審查申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-06-18-1912-v66sly","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"19:12:09","subject":"本公司經櫃買中心同意，自115年06月22日起恢復交易。","clause":"第40款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-06-18 19:12，「本公司經櫃買中心同意，自115年06月22日起恢復交易。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-06-18-1909-1lud6w4","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"19:09:45","subject":"公告本公司召開重大訊息記者會新聞稿內容","clause":"第53款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-06-18 19:09，「公告本公司召開重大訊息記者會新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-06-18-1906-1f9k08r","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"19:06:49","subject":"代子公司華鋒科技股份有限公司向關係人租賃取得不動產使用權資產","clause":"第20款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-06-18 19:06，「代子公司華鋒科技股份有限公司向關係人租賃取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-06-18-1903-1aidyts","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"19:03:33","subject":"公告本公司擬取得安星製藥股份有限公司76%股權","clause":"第20款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-06-18 19:03，「公告本公司擬取得安星製藥股份有限公司76%股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2026-06-18-1852-7qlqag","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"18:52:39","subject":"公告本公司召開法人說明會之相關資訊","clause":"第30款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2026-06-18 18:52，「公告本公司召開法人說明會之相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-06-18-1740-1o5mfha","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"17:40:50","subject":"公告本公司策略長異動","clause":"第8款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-06-18 17:40，「公告本公司策略長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2026-06-18-1726-jflio5","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:26:22","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2026-06-18 17:26，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1718-133oehh","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:18:13","subject":"公告本公司新任獨立董事當選人林岱蓉未就任事宜","clause":"第6款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:18，「公告本公司新任獨立董事當選人林岱蓉未就任事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1716-13sk2v0","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:16:50","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:16，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1715-51g63i","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:15:11","subject":"公告本公司第六屆董事會推選董事長","clause":"第6款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:15，「公告本公司第六屆董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1714-1kbz80x","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:14:09","subject":"公告本公司115年股東常會解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:14，「公告本公司115年股東常會解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1713-44y80g","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:13:34","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)暨董事變動達三分之一","clause":"第6款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:13，「公告本公司115年股東常會全面改選董事(含獨立董事)暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-06-18-1712-15i5ka5","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"17:12:51","subject":"本公司115年股東常會通過解除董事競業禁止之限制案","clause":"第21款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-06-18 17:12，「本公司115年股東常會通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-06-18-1712-1jb8ii5","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"17:12:24","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-06-18 17:12，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-06-18-1705-cwi4y1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"17:05:17","subject":"本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日已取得澳洲主管機關HREC核准執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-06-18 17:05，「本公司新藥CBL-514注射劑用於減少腹部皮下脂肪之第二個多國多中心樞紐三期臨床試驗CBL-0302申請，今日已取得澳洲」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-06-18-1655-1h4amny","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"16:55:40","subject":"本公司受邀參加臺灣證券交易所舉辦之創新板公司法人說明會","clause":"第12款","fact_date":"2026-06-22","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-06-18 16:55，「本公司受邀參加臺灣證券交易所舉辦之創新板公司法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-06-18-1641-1pkfpi3","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"16:41:20","subject":"代子公司Lotus Pharma Bulgaria EOOD公告資金貸與案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-06-18 16:41，「代子公司Lotus Pharma Bulgaria EOOD公告資金貸與案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-06-18-1631-gc72i5","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"16:31:22","subject":"本公司受邀參加由元大證券舉辦之法人說明會，說明本公司之營運概況。","clause":"第12款","fact_date":"2026-06-29","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-06-18 16:31，「本公司受邀參加由元大證券舉辦之法人說明會，說明本公司之營運概況。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-06-18-1628-1kxwrjh","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"16:28:37","subject":"公告本公司民國115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-06-18 16:28，「公告本公司民國115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-06-18-1627-1wnx7q8","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"16:27:28","subject":"公告法人董事指派代表人出席115/06/18股東會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-06-18 16:27，「公告法人董事指派代表人出席115/06/18股東會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-06-18-1602-105zg83","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"16:02:00","subject":"代重要子公司Acepodia Biotech, Inc.公告研發中新藥ACE1831用以治療復發/難治型CD20表現之B細胞瘤，已完成第一期臨床試驗之最終臨床試驗報告","clause":"第8款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-06-18 16:02，「代重要子公司Acepodia Biotech, Inc.公告研發中新藥ACE1831用以治療復發/難治型CD20表現之B」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4131-2026-06-18-1530-1shitx5","company_id":"4131","company":"浩泰","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"15:30:40","subject":"代子公司八億實業股份有限公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：浩泰（4131），2026-06-18 15:30，「代子公司八億實業股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-06-18-1525-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-06-18","time":"15:25:16","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-06-18 15:25，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-06-18-1523-v8gwjg","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"15:23:56","subject":"公告本公司預計於新台幣3億元額度內取得有價證券","clause":"第20款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-06-18 15:23，「公告本公司預計於新台幣3億元額度內取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-18-1523-1lnd99o","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"15:23:40","subject":"公告更正本公司115年股東常會改選董事(含獨立董事)當選名單(董事姓名誤植及董事變動資訊更正)","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-18 15:23，「公告更正本公司115年股東常會改選董事(含獨立董事)當選名單(董事姓名誤植及董事變動資訊更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2026-06-18-1513-1jb8ii5","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2026-06-18","time":"15:13:22","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2026-06-18 15:13，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-06-18-1445-12qcz60","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"14:45:49","subject":"代子公司(聲博科技)公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-06-18 14:45，「代子公司(聲博科技)公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2026-06-18-1117-ssvo5d","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2026-06-18","time":"11:17:31","subject":"115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2026-06-18 11:17，「115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}